Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors
Ioannis Kaffes(Emory University), Dolores Hambardzumyan(Icahn School of Medicine at Mount Sinai), Cameron J. Herting(Emory University), Jason T. Huse(The University of Texas MD Anderson Cancer Center), Ben Gabanic(Emory University), Patrick J. Cimino(National Institute of Neurological Disorders and Stroke), José E. Velázquez Vega(Emory University), James Ross(Emory University), Leon McSwain(Emory University), Jeffrey M. Switchenko(Emory University), Sven Nelander(Uppsala University), Karin Forsberg‐Nilsson(Uppsala University), Eric C. Holland(Fred Hutch Cancer Center), Daniel J. Brat(Northwestern University), Naga Prathyusha Maturi(Uppsala University), Helmut Kettenmann(Max Delbrück Center), Cameron Brennan(Memorial Sloan Kettering Cancer Center), Bengt Westermark(Science for Life Laboratory), Zhihong Chen(Icahn School of Medicine at Mount Sinai), Frank Szulzewsky(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jennifer Shelton(Emory University), Lene Uhrbom(Uppsala University)
Cited by 168
Related Papers
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
|Physiological Reviews|1999|2.5k